Home » Study shows promise for virus specific T cell therapy following bone marrow transplant
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital published new results in the medical journal, Science Translational Medicine, from a clinical study that evaluated the use of virus specific T cells grown in their laboratory to treat and prevent severe infections in immunocompromised patients who have undergone a bone marrow transplant as treatment for certain types of cancer or other hematologic and immune disorders.
The study showed the new therapy provided a 94 percent virological response rate in the patients studied, which is more effective than current antiviral therapies.
June 25, 2014
by Baylor College of Medicine